CAREDX, INC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.83 USD | +34.09% |
|
+52.57% | +23.58% |
| May. 10 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
| May. 10 | CareDx Shares Rise After Q1 Results Beat Estimates | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 915.3 | 3,569 | 2,401 | 610.9 | 649.2 | 771.3 | - | - |
| Enterprise Value (EV) 1 | 915.3 | 3,569 | 2,053 | 317.8 | 413.8 | 771.3 | 771.3 | 771.3 |
| P/E ratio | -41.5 x | -181 x | -77.1 x | -7.92 x | -3.39 x | -10.4 x | -12.9 x | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 7.2 x | 18.6 x | 8.1 x | 1.9 x | 2.32 x | 2.84 x | 2.64 x | 2.32 x |
| EV / Revenue | 7.2 x | 18.6 x | 8.1 x | 1.9 x | 2.32 x | 2.84 x | 2.64 x | 2.32 x |
| EV / EBITDA | 220 x | 448 x | 135 x | -34.8 x | -17.1 x | -29.5 x | -172 x | 62.3 x |
| EV / FCF | -184,174,060 x | - | - | - | - | - | - | - |
| FCF Yield | -0% | - | - | - | - | - | - | - |
| Price to Book | - | - | - | 1.42 x | - | - | - | - |
| Nbr of stocks (in thousands) | 42,436 | 49,257 | 52,802 | 53,537 | 54,098 | 52,008 | - | - |
| Reference price 2 | 21.57 | 72.45 | 45.48 | 11.41 | 12.00 | 14.83 | 14.83 | 14.83 |
| Announcement Date | 2/27/20 | 2/24/21 | 2/24/22 | 2/27/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 127.1 | 192.2 | 296.4 | 321.8 | 280.3 | 272 | 292.5 | 332.8 |
| EBITDA 1 | 4.164 | 7.962 | 17.83 | -17.54 | -37.98 | -26.1 | -4.491 | 12.38 |
| EBIT 1 | -24.53 | -22.53 | -29.73 | -77.23 | -203.4 | -85 | -72.95 | - |
| Operating Margin | -19.31% | -11.72% | -10.03% | -24% | -72.55% | -31.25% | -24.94% | - |
| Earnings before Tax (EBT) 1 | -23.95 | -19.75 | -32.09 | -76.23 | -190.1 | -73.61 | -62.19 | - |
| Net income 1 | -21.97 | -18.71 | -30.66 | -76.61 | -190.3 | -73.58 | -62.03 | - |
| Net margin | -17.29% | -9.74% | -10.34% | -23.81% | -67.88% | -27.05% | -21.21% | - |
| EPS 2 | -0.5200 | -0.4000 | -0.5900 | -1.440 | -3.540 | -1.420 | -1.150 | - |
| Free Cash Flow | -4.97 | - | - | - | - | - | - | - |
| FCF margin | -3.91% | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 2/24/21 | 2/24/22 | 2/27/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 79.22 | 79.42 | 80.63 | 79.36 | 82.38 | 77.26 | 70.3 | 67.19 | 65.57 | 72.05 | 66.57 | 68.93 | 69.51 | 72.5 | 71.16 |
| EBITDA 1 | -1.358 | -5.649 | -5.733 | -2.476 | -3.676 | -6.415 | -10.35 | -10.95 | -10.27 | -1.856 | -7.944 | -5.187 | -4.202 | -2.811 | -2.044 |
| EBIT 1 | -15.4 | -19.05 | -21.72 | -17.34 | -19.12 | -24.32 | -27.62 | -28.78 | -122.6 | -19.34 | -22.94 | -20.65 | -22.08 | -20.93 | -18.99 |
| Operating Margin | -19.44% | -23.99% | -26.94% | -21.85% | -23.21% | -31.48% | -39.29% | -42.84% | -187.03% | -26.84% | -34.45% | -29.95% | -31.77% | -28.87% | -26.68% |
| Earnings before Tax (EBT) 1 | -17.05 | -19.66 | -21.75 | -16.67 | -18.16 | -23.62 | -25.02 | -23.56 | -117.9 | -16.74 | -19.94 | -17.75 | -19.18 | -18.17 | -16.29 |
| Net income 1 | -16.15 | -19.65 | -21.7 | -16.94 | -18.33 | -23.75 | -24.95 | -23.48 | -118.1 | -16.66 | -19.96 | -17.76 | -19.2 | -18.13 | -16.25 |
| Net margin | -20.39% | -24.74% | -26.91% | -21.34% | -22.25% | -30.74% | -35.49% | -34.95% | -180.11% | -23.12% | -29.98% | -25.77% | -27.62% | -25.01% | -22.84% |
| EPS 2 | -0.3100 | -0.3700 | -0.4100 | -0.3200 | -0.3400 | -0.4400 | -0.4600 | -0.4300 | -2.210 | -0.3200 | -0.4025 | -0.3350 | -0.3325 | -0.3400 | -0.3033 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/22 | 5/5/22 | 8/4/22 | 11/3/22 | 2/27/23 | 5/10/23 | 8/8/23 | 11/8/23 | 2/28/24 | 5/9/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | 348 | 293 | 235 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | -4.97 | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | 8.050 | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | 2.2 | - | - | - | - | - | - | - |
| Capex / Sales | 1.73% | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 2/24/21 | 2/24/22 | 2/27/23 | 2/28/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
14.83
USD
Average target price
14.4
USD
Spread / Average Target
-2.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.58% | 771M | |
| -27.67% | 9.87B | |
| +34.87% | 3.07B | |
| -17.30% | 2.74B | |
| -11.15% | 2.24B | |
| -22.32% | 1.63B | |
| -1.31% | 760M | |
| -28.57% | 516M | |
| +5.37% | 310M | |
| +12.46% | 219M |
- Stock Market
- Equities
- CDNA Stock
- Financials CareDx, Inc